Cedric Francois Salary and Compensation - Apellis Pharmaceuticals, Inc. CEO Pay 2025

In fiscal year 2025, Cedric Francois, M.D., Ph.D.(5) President & Chief Executive Officer of Apellis Pharmaceuticals, Inc. (APLS), received total compensation of $13.3 million.

Cedric Francois's compensation breakdown includes: base salary of $822K, bonus of $347K, stock awards valued at $9.7 million, option awards of $2.5 million, and other compensation of $16K.

Compared to fiscal year 2024, Cedric Francois's total compensation increased 22% from $11.0 million to $13.3 million.

Apellis Pharmaceuticals, Inc. (APLS) Executive Pay 2025

Apellis Pharmaceuticals, Inc.'s top 5 named executive officers received combined total compensation of $32.2 million in fiscal year 2025.

The named executive officers disclosed in Apellis Pharmaceuticals, Inc.'s 2025 proxy statement are:Cedric Francois (M.D., Ph.D.(5) President & Chief Executive Officer) with total compensation of $13.3 million, Timothy Sullivan (Chief Financial Officer) with total compensation of $5.0 million, David Watson (General Counsel) with total compensation of $4.7 million, Caroline Baumal (M.D. Chief Medical Officer) with total compensation of $4.6 million, and Kelley Boucher (Chief People Officer) with total compensation of $4.5 million.